Harmonization of molecular monitoring of CML therapy in Europe von Müller, M C, Cross, N C P, Erben, P, Schenk, T, Hanfstein, B, Ernst, T, Hehlmann, R, Branford, S, Saglio, G, Hochhaus, A

Volltext

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib von Hochhaus, A, Baccarani, M, Deininger, M, Apperley, J F, Lipton, J H, Goldberg, S L, Corm, S, Shah, N P, Cervantes, F, Silver, R T, Niederwieser, D, Stone, R M, Dombret, H, Larson, R A, Roy, L, Hughes, T, Müller, M C, Ezzeddine, R, Countouriotis, A M, Kantarjian, H M

Volltext

Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy von Müller, M. C. A., Straat, M., Meijers, J. C. M., Klinkspoor, J. H., Jonge, E., Arbous, M. S., Schultz, M. J., Vroom, M. B., Juffermans, N. P.

Volltext

Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy: reply von Müller, M. C. A., Juffermans, N. P.

Volltext

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) von Hanfstein, B, Müller, M C, Hehlmann, R, Erben, P, Lauseker, M, Fabarius, A, Schnittger, S, Haferlach, C, Göhring, G, Proetel, U, Kolb, H-J, Krause, S W, Hofmann, W-K, Schubert, J, Einsele, H, Dengler, J, Hänel, M, Falge, C, Kanz, L, Neubauer, A, Kneba, M, Stegelmann, F, Pfreundschuh, M, Waller, C F, Branford, S, Hughes, T P, Spiekermann, K, Baerlocher, G M, Pfirrmann, M, Hasford, J, Saußele, S, Hochhaus, A

Volltext

The effect of C1-inhibitor in a murine model of transfusion-related acute lung injury von Müller, M. C. A., Stroo, I., Wouters, D., Zeerleder, S. S., Roelofs, J. J. T. H., Boon, L., Vroom, M. B., Juffermans, N. P.

Volltext

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia von Hochhaus, A, O'Brien, S G, Guilhot, F, Druker, B J, Branford, S, Foroni, L, Goldman, J M, Müller, M C, Radich, J P, Rudoltz, M, Mone, M, Gathmann, I, Hughes, T P, Larson, R A

Volltext

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias von Cortes, J.E, Kim, D.-W, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F.E, Apperley, J.F, Khoury, H.J, Talpaz, M, DiPersio, J, DeAngelo, D.J, Abruzzese, E, Rea, D, Baccarani, M, Müller, M.C, Gambacorti-Passerini, C, Wong, S, Lustgarten, S, Rivera, V.M, Clackson, T, Turner, C.D, Haluska, F.G, Guilhot, F, Deininger, M.W, Hochhaus, A, Hughes, T, Goldman, J.M, Shah, N.P, Kantarjian, H

Volltext

Standardized definitions of molecular response in chronic myeloid leukemia von Cross, N C P, White, H E, Müller, M C, Saglio, G, Hochhaus, A

Volltext

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV von Kalmanti, L, Saussele, S, Lauseker, M, Müller, M C, Dietz, C T, Heinrich, L, Hanfstein, B, Proetel, U, Fabarius, A, Krause, S W, Rinaldetti, S, Dengler, J, Falge, C, Oppliger-Leibundgut, E, Burchert, A, Neubauer, A, Kanz, L, Stegelmann, F, Pfreundschuh, M, Spiekermann, K, Scheid, C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R

Volltext

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML von Schütz, C, Inselmann, S, Sausslele, S, Dietz, C T, Müller, M C, Eigendorff, E, Brendel, C A, Metzelder, S K, Brümmendorf, T H, Waller, C, Dengler, J, Goebeler, M E, Herbst, R, Freunek, G, Hanzel, S, Illmer, T, Wang, Y, Lange, T, Finkernagel, F, Hehlmann, R, Huber, M, Neubauer, A, Hochhaus, A, Guilhot, J, Xavier Mahon, F, Pfirrmann, M, Burchert, A

Volltext

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia von Cross, N C P, White, H E, Colomer, D, Ehrencrona, H, Foroni, L, Gottardi, E, Lange, T, Lion, T, Machova Polakova, K, Dulucq, S, Martinelli, G, Oppliger Leibundgut, E, Pallisgaard, N, Barbany, G, Sacha, T, Talmaci, R, Izzo, B, Saglio, G, Pane, F, Müller, M C, Hochhaus, A

Volltext

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy von HOCHHAUS, A, KREIL, S, GSCHAIDMEIER, H, DRUKER, B. J, HEHLMANN, R, CORBIN, A. S, ROSEE, P. La, MÜLLER, M. C, LAHAYE, T, HANFSTEIN, B, SCHOCH, C, CROSS, N. C. P, BERGER, U

Volltext

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia von Beenen, L.F.M., Bos, L.D., Scheerder, M.J., Lobé, N.H.J., Muller, M.C.A., Schultz, M.J., van den Aardweg, J.G., Goorhuis, A., Bonta, P.I., Middeldorp, S., Vlaar, A.P.

Volltext

Evaluation of a multi-center randomised clinical trial on prophylactic transfusion of fresh frozen plasma: implications for future trials von Müller, M. C. A., de Haan, R. J., Vroom, M. B., Juffermans, N. P.

Volltext

Polychaete nervous systems: Ground pattern and variations—cLS microscopy and the importance of novel characteristics in phylogenetic analysis von Muller, M. C. M.

Volltext

A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases von Grossmann, V, Kohlmann, A, Zenger, M, Schindela, S, Eder, C, Weissmann, S, Schnittger, S, Kern, W, Müller, M C, Hochhaus, A, Haferlach, T, Haferlach, C

Volltext

Kink far below the Fermi level reveals new electron-magnon scattering channel in Fe von Młyńczak, E., Müller, M. C. T. D., Gospodarič, P., Heider, T., Aguilera, I., Bihlmayer, G., Gehlmann, M., Jugovac, M., Zamborlini, G., Tusche, C., Suga, S., Feyer, V., Plucinski, L., Friedrich, C., Blügel, S., Schneider, C. M.

Volltext

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV von Miranda, M B, Lauseker, M, Kraus, M-P, Proetel, U, Hanfstein, B, Fabarius, A, Baerlocher, G M, Heim, D, Hossfeld, D K, Kolb, H-J, Krause, S W, Nerl, C, Brümmendorf, T H, Verbeek, W, Fauser, A A, Prümmer, O, Neben, K, Hess, U, Mahlberg, R, Plöger, C, Flasshove, M, Rendenbach, B, Hofmann, W-K, Müller, M C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R, Saußele, S

Volltext

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma von METZGEROTH, G, WALZ, C, MÜLLER, M. C, BENEKE, H, MÜLLER, L, DEL VALLE, F, AULITZKY, W. E, WITTKOWSKY, G, SCHMITZ, N, SCHULTE, C, MULLER-HERMELINK, K, HODGES, E, SCORE, J, WHITTAKER, S. J, DIECKER, F, DÖHNER, H, SCHULD, P, HEHLMANN, R, HOCHHAUS, A, CROSS, N. C. P, REITER, A, SIEBERT, R, SCHNITTGER, S, HAFERLACH, C, POPP, H, HAFERLACH, T, ERBEN, P, MIX, J

Volltext